4//SEC Filing
Davis Andrew 4
Accession 0000950170-24-063482
CIK 0001446847other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:05 PM ET
Size
4.9 KB
Accession
0000950170-24-063482
Insider Transaction Report
Form 4
Davis Andrew
SVP, Chief Business Officer
Transactions
- Sale
Class A Common Stock
2024-05-20$6.45/sh−22,725$146,576→ 288,031 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and performance-based restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeother
Related Parties
1- filerCIK 0001932525
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 4:05 PM ET
- Size
- 4.9 KB